Merge Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Merge Therapeutics General Information

Description

Operator of a biotechnology company intended to accelerate therapeutic research and development. The company develops dual-depleting macrophage engager antibodies for the treatment of immune-mediated diseases, enabling medical professionals to improve the lives of patients who live with autoimmune and chronic inflammatory diseases.

Contact Information

Website
mergetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 108 Morning Sun Avenue
  • Mill Valley, CA 94941
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 108 Morning Sun Avenue
  • Mill Valley, CA 94941
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 16-Jun-2025 Completed Startup
2. Early Stage VC 01-Jan-2025 Completed Startup
1. Accelerator/Incubator 01-Jan-2025 Completed Startup
To view Merge Therapeutics’s complete valuation and funding history, request access »

Merge Therapeutics Patents

Merge Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026073139-A1 Bispecific antibodies and methods of use thereof Pending 30-Sep-2024

Merge Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
Mission BioCapital Venture Capital Minority
Roche Venture Fund Corporate Venture Capital Minority
Termeer Institute Accelerator/Incubator
To view Merge Therapeutics’s complete investors history, request access »

Merge Therapeutics FAQs

  • When was Merge Therapeutics founded?

    Merge Therapeutics was founded in 2024.

  • Where is Merge Therapeutics headquartered?

    Merge Therapeutics is headquartered in Mill Valley, CA.

  • What industry is Merge Therapeutics in?

    Merge Therapeutics’s primary industry is Drug Discovery.

  • Is Merge Therapeutics a private or public company?

    Merge Therapeutics is a Private company.

  • What is Merge Therapeutics’s current revenue?

    The current revenue for Merge Therapeutics is .

  • Who are Merge Therapeutics’s investors?

    Johnson & Johnson Innovation - JLABS, Mission BioCapital, Roche Venture Fund, and Termeer Institute have invested in Merge Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process